Crohn's Disease
Clinical research is investigating the potential of mesenchymal stem cells (MSCs) in Crohn’s disease. Studies focus on safety, feasibility, and possible immunomodulatory properties, contributing to the evolving evidence base in Inflammatory Bowel Disease (IBD).
Crohn’s disease is a chronic form of IBD that causes ongoing inflammation of the digestive tract, most often in the small intestine and colon. Common symptoms include abdominal pain, diarrhea, and weight loss. Conventional therapies may reduce inflammation but do not provide a cure, and many patients continue to experience relapses.
Ongoing MSC clinical trials aim to assess whether their immune-regulating and tissue-repairing properties could support disease management. While research remains at an exploratory stage, these studies are expanding scientific understanding of how cell-based approaches might contribute to future IBD treatment strategies.
Clinical Trials